Delayed preconditioning induced by lipoteichoic acid from B. Subtilis and S. Aureus is not blocked by administration of 5-hydroxydecanoate

Shock

Volumn 17, Issue 1, 2002, Pages 19-22

  Zacharowski, Kai ^a   Chatterjee, Prabal K ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 HD; Bacteria; LTA; Mitochondrial KATP channel; Myocardial infarct size; Rat

Indexed keywords

5 HYDROXYDECANOIC ACID; 5-HYDROXYDECANOIC ACID; DECANOIC ACID DERIVATIVE; HYDROXYACID; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; TEICHOIC ACID;

ANIMAL; ARTICLE; BACILLUS SUBTILIS; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION PREVENTION; HEMODYNAMICS; MALE; PATHOLOGY; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; WISTAR RAT;

ANIMALS; BACILLUS SUBTILIS; DECANOIC ACIDS; HEMODYNAMIC PROCESSES; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 0036358504     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200201000-00004     Document Type: Article

References (42)

1. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986.
2. Baxter GF, Marber MS, Patel VC, Yellon DM: Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90:2993-3000, 1994.
3. Marber MS, Latchman DS, Walker JM, Yellon DM: Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264-1272, 1993.
4. Zacharowski K, Otto M, Hafner G, Chatterjee PK, Thiemermann C: Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology. Arterioscler Thromb Vasc Biol 19:2276-2280, 1999.
5. Zacharowski K, Frank S, Otto M, Chatterjee PK, Cuzzocrea S, Hafner G, Pfeilschifter J, Thiemermann C: Lipoteichoic acid induces delayed protection in the rat heart: a comparison with endotoxin. Arterioscler Thromb Vasc Biol 20:1521-1528, 2000.
6. Tang XL, Qiu Y, Park SW, Sun JZ, Kalya A, Bolli R: Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 79: 424-434, 1996.
7. Vegh A, Papp JG, Parratt JR: Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 113:1081-1082, 1994.
8. Kaeffer N, Richard V, Thuillez C: Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals. Circulation 96:2311-2316, 1997.
9. Brown JM, Grosso MA, Terada LS, Whitman GJ, Banerjee A, White CW, Harken AH, Repine JE: Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA 86:2516-2520, 1989.
10. Yao Z, Auchampach JA, Pieper GM, Gross GJ: Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res 27:832-838, 1993.
11. Elliott GT, Sowell CG, Walker EB, Weber PA, Moore J, Gross GJ: The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs. J Mol Cell Cardiol 32:1327-1339, 2000.
12. Xi L, Salloum F, Tekin D, Jarrett NC, Kukreja RC: Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Am J Physiol 277:H2418-H2424, 1999.
13. Wakabayashi G, Gelfand JA, Jung WK, Connolly RJ, Burke JF, Dinarello CA: Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia: comparison to Escherichia coli. J Clin Invest 87:1925-1935, 1991.
14. Bone RC: Gram-positive organisms and sepsis. Arch Intern Med 154:26-34, 1994.
15. Fischer W: Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol 29:233-302, 1988.
16. Himanen JP, Pyhala L, Olander RM, Merimskaya O, Kuzina T, Lysyuk O, Pronin A, Sanin A, Helander IM, Sarvas M: Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg). J Gen Microbiol 139:2659-2665, 1993.
17. Himanen JP, Sarvas M, Helander IM: Assessment of non-protein impurities in potential vaccine proteins produced by Bacillus subtilis. Vaccine 11:970-973, 1993.
18. Noma A: ATP-regulated K+ channels in cardiac muscle. Nature 305:147-148, 1983.
19. Gross GJ, Kersten JR, Warltier DC: Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg 68:1898-1904, 1999.
20. Grover GJ, Garlid KD: ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32:677-695, 2000.
21. Baxter GF, Yellon DM: ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation. J Mol Cell Cardiol 31: 981-989, 1999.
22. Liang BT, Gross GJ: Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 84:1396-1400, 1999.
23. Mei DA, Elliott GT, Gross GJ: KATP channels mediate late preconditioning against infarction produced by monophosphoryl lipid A. Am J Physiol 271:H2723-H2729, 1996.
24. Sasaki N, Sato T, Ohler A, O'Rourke B, Marban E: Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101:439-445, 2000.
25. Xi L, Jarrett NC, Hess ML, Kukreja RC: Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation 99: 2157-2163, 1999.
26. Hoag JB, Qian YZ, Nayeem MA, D'Angelo M, Kukreja RC: ATP-sensitive potassium channel mediates delayed ischemic protection by heat stress in rabbit heart. Am J Physiol 273:H2458-H2464, 1997.
27. Baller D, Bretschneider HJ, Hellige G: A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res Cardiol 76:163-181, 1981.
28. Weisman HF, Bartow T, Leppo MK, Marsh HC, Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146-151, 1990.
29. Fischer W, Koch HU, Haas R: Improved preparation of lipoteichoic acids. Eur J Biochem 133:523-530, 1983.
30. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, Wu WJ, Bolli R: Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 273:H2931-H2936, 1997.
31. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK: The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81:1094-1107, 1997.
32. Takano H, Tang XL, Qiu Y, Guo Y, French BA, Bolli R: Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res 83:73-84, 1998.
33. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, Bolli R: The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96:11507-11512, 1999.
34. Yamashita N, Nishida M, Hoshida S, Kuzuya T, Hori M, Taniguchi N, Kamada T, Tada M: Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 94:2193-2199, 1994.
35. Grover GJ: Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 75:309-315, 1997.
36. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, Grover GJ: Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: possible mechanism of cardioprotection. Circ Res 81:1072-1082, 1997.
37. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ: Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res 84:846-851, 1999.
38. Zacharowski K, Olbrich A, Piper J, Hafner G, Kondo K, Thiemermann C: Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents. Arterioscler Thromb Vasc Biol 19:2141-2147, 1999.
39. Zacharowski K, Olbrich A, Otto M, Hafner G, Thiemermann C: Effects of the prostanoid EP3-receptor agonists M&B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaesthetized rat. Br J Pharmacol 126:849-858, 1999.
40. Hide EJ, Thiemermann C: Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol 118:1409-1414, 1996.
41. Takashi E, Wang Y, Ashraf M: Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 85:1146-1153, 1999.
42. Pell TJ, Yellon DM, Goodwin RW, Baxter GF: Myocardial ischemic tolerance following heat stress is abolished by ATP-sensitive potassium channel blockade. Cardiovasc Drugs Ther 11:679-686, 1997.